Episode Thumbnail
Episode 177  |  47:52 min

5 Actionable Lessons Learned from the RADx Initiative by NIH

Episode 177  |  47:52 min  |  01.27.2021

5 Actionable Lessons Learned from the RADx Initiative by NIH

00:00
00:00
This is a podcast episode titled, 5 Actionable Lessons Learned from the RADx Initiative by NIH. The summary for this episode is: Rapid Acceleration of Diagnostics (RADx) is an initiative launched by the National Institutes of Health (NIH) aimed at accelerating the development, commercialization, and implementation of COVID-19 testing technologies that shorten viral detection cycles and increase access to reliable, accurate testing on a widespread scale. In this episode of the Global Medical Device Podcast, Jon Speer talks to Devon Campbell, founder of Prodct, who has been a major contributor in supporting the efforts being made by RADx teams. Listen as Jon and Devon share five actionable lessons learned from Devon’s involvement with RADx, each of which can be applied by medical device companies across the board.
Takeaway 1 | 00:51 MIN
Greenlight Guru involvement with RadX

Rapid Acceleration of Diagnostics (RADx) is an initiative launched by the National Institutes of Health (NIH) aimed at accelerating the development, commercialization, and implementation of COVID-19 testing technologies that shorten viral detection cycles and increase access to reliable, accurate testing on a widespread scale.

In this episode of the Global Medical Device Podcast, Jon Speer talks to Devon Campbell, founder of Prodct, who has been a major contributor in supporting the efforts being made by RADx teams.

Listen as Jon and Devon share five actionable lessons learned from Devon’s involvement with RADx, each of which can be applied by medical device companies across the board.

Some highlights of this episode include:

  • What is RADx Tech? Initiative that aims to speed the development, validation, and commercialization of innovative point-of-care and home-based tests. Also, it tries to improve clinical laboratory tests to specifically detect COVID-19.
  • Common characteristics of RADx team projects include companies:Generating abundant data and running experiments quickly.
    Without medical device leadership or product development experience.
    Managing development while building infrastructure and fundraising.
  • Lesson 1: Protect the data, build credibility, and remove vulnerabilities to capture credit and establish indelible data for those that invalidate data or question work.
  • Lesson 2: Start documentation, introduce design controls, and review/revise product development.
  • Lesson 3: Build and maintain Technical Advisory Boards to offer feedback that accelerates product development/commercialization based on experience.
  • Lesson 4: Interconnect different functions involved to develop a product. Start with the end in mind to develop a strategic roadmap to take fast but small steps.
  • Lesson 5: Manage risk mitigation from product, business, scalability, manufacturability, and other perspectives.

Memorable quotes from this episode:

“Its aim is to speed the development, the validation, and the commercialization of innovative point-of-care and home-based tests. It’s also looking to try to improve clinical laboratory tests, anything else in that diagnostic space, specifically to detect COVID-19 and the virus.” Devon Campbell

“It’s amazing, the number of hurdles that are cleared in order for some of these technologies to be able to find their way to the market, still in a safe and efficacious way.” Devon Campbell

“There’s a lot in this situation that forces the teams to be hyper-sensitive to efficiency and speed, while still maintaining safety and regulatory expectations.” Devon Campbell

“These are teams that are used to gathering data and running experiments. They’re not used to being a medical device company.” Jon Speer

More Episodes

Focusing on the Intent of the UDI Requirements from FDA's Final Guidance Doc

Addressing the 'Who, What, When' of Quality in the Medical Device Industry

Meet a Guru: Maryann Mitchell

Why Storytelling Matters for Medical Device Companies

A Breakthrough Device that Aims to Prevent Osteoporosis

Understanding FDA's New Intended Use Rule and its Implications